Friday, October 2, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 9, 2025

Everyone's getting richer in the US, but boomers most of all. Why it's not sitting well with young Americans

View original at finance.yahoo.com
Everyone's getting richer in the US, but boomers most of all. Why it's not sitting well with young Americans Galyna Andrushko/Envato Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • 7-step plan works every single time to kill debt and get rich, and anyone can do it

    80% confidence
  • Nearly 50% of Americans are making 1 big Social Security mistake

    80% confidence
  • Young people's net worth has technically improved due to compounding time advantage, but the gap with boomers remains vast

    80% confidence
  • One asset will surge 400% in a year

    80% confidence
  • Baby boomers hold the lion's share of U.S. wealth and are pulling even further ahead

    80% confidence
  • Boomers' stock portfolios from 401(k)s, IRAs and mutual funds had skyrocketed by 2022 versus the American average

    80% confidence
  • Set it and forget it strategy with low-cost index funds beats trying to time the market

    80% confidence
  • Homeownership rose sharply for oldest Americans between 1983 and 2022 and remained high

    80% confidence
  • Wealth gap widening is driven by three primary factors: stocks, homeownership, and debt

    80% confidence
  • Vanguard reveals what could be coming for U.S. stocks, raising alarm bells for retirees

    80% confidence
  • Young families took on debt while older Americans shed it, with mortgage debt swelling for youngest households while falling for oldest

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com
Everyone's getting richer in the US, but boomers most of all. Why it's not sitting well with young Americans — Source | Via News | Finance Via News